HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exosomes from CIITA-transfected CT26 cells enhance anti- tumor effects.

AbstractAIM:
To study anti-tumor effects of exosomes from class II transactivator (CIITA) gene transfected CT26 cells.
METHODS:
In this study, we established an MHC class II molecule-expressing murine colon cancer cell line (CT26-CIITA) by transduction of the CIITA gene. Immune effects in vitro and tumor protective results in vivo were tested and monitored.
RESULTS:
Exosomes from CT26-CIITA cells were found to contain a high level of MHC class II protein. When loaded on dendritic cells (DCs), exosomes from CT26-CIITA cells significantly increased expression of MHC class II molecules, CD86 and CD80, as compared to exosomes from CT26 cells. In vitro assays using co-culture of immunized splenocytes and exosome-loaded DCs demonstrated that CIITA- Exo enhanced splenocyte proliferation and IFN-γ production of CD4+T cells, while inhibiting IL-10 secretion. In addition, compared to exosomes from CT26 cells, CT26-CIITA-derived exosomes induced higher TNF-α and IL-12 mRNA levels. A mouse tumour preventive model showed that CT26-CIITA derived exosomes significantly inhibited tumour growth in a dose-dependent manner and significantly prolonged the survival time of tumour- bearing mice.
CONCLUSION:
Our findings indicate that CT26-CIITA-released exosomes are more efficient to induce anti-tumour immune responses, suggesting a potential role of MHC class II-containing tumour exosomes as cancer vaccine candidates.
AuthorsWen Fan, Xing-De Tian, E Huang, Jia-Jun Zhang
JournalAsian Pacific journal of cancer prevention : APJCP (Asian Pac J Cancer Prev) Vol. 14 Issue 2 Pg. 987-91 ( 2013) ISSN: 2476-762X [Electronic] Thailand
PMID23621273 (Publication Type: Journal Article)
Chemical References
  • B7-1 Antigen
  • B7-2 Antigen
  • Cancer Vaccines
  • IL10 protein, mouse
  • MHC class II transactivator protein
  • Nuclear Proteins
  • RNA, Messenger
  • Trans-Activators
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Interleukin-12
  • Interferon-gamma
Topics
  • Animals
  • B7-1 Antigen (metabolism)
  • B7-2 Antigen (metabolism)
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Cancer Vaccines
  • Cell Line, Tumor
  • Cell Proliferation
  • Colonic Neoplasms (immunology, metabolism)
  • Dendritic Cells (metabolism)
  • Disease Models, Animal
  • Exosomes (immunology, metabolism)
  • Interferon-gamma (blood, metabolism)
  • Interleukin-10 (blood, metabolism)
  • Interleukin-12 (blood, genetics)
  • Mice
  • Mice, Inbred BALB C
  • Nuclear Proteins (genetics)
  • RNA, Messenger (biosynthesis)
  • Spleen (cytology, metabolism)
  • Trans-Activators (genetics)
  • Transfection
  • Tumor Necrosis Factor-alpha (blood, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: